Person

Jess Roper

Formerly Former SVP, CFO, Dexcom

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$2.2M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • DXCM
    Dexcom
    Former SVP, CFO
    2016 or earlier – last filing Apr 2017

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Mar 22, 2017DXCMSale2,000$75.97$152K
Feb 22, 2017DXCMSale2,333$78.76$184K
Jan 18, 2017DXCMSale3,012$85.01$256K
Dec 14, 2016DXCMSale2,442$64.14$157K
Oct 24, 2016DXCMSale2,471$80.75$200K
Sep 22, 2016DXCMSale2,470$93.99$232K
Jun 7, 2016DXCMSale3,471$69.00$239K
Apr 25, 2016DXCMSale3,471$69.00$239K
Mar 31, 2016DXCMSale3,470$69.00$239K
Jan 22, 2016DXCMSale3,518$72.97$257K

SEC reporting-owner ID (CIK) 1408993 · all filings on EDGAR